English | Español
Jamie Barrand | Sep 23, 2015

Data looks favorable for Trovagene's HPV HR test
Jamie Barrand | Sep 22, 2015

AntriaBio adds Type 2 diabetes treatment to product candidate line
Daniel Daw | Sep 22, 2015

Allergan challenges Rytary generic patent

Michael Gardiner | Sep 20, 2015

FDA approves VRAYLAR (cariprazine) capsules
Michael Gardiner | Sep 20, 2015

Bayer HealthCare will showcase oncology data at ECC2015
Michael Gardiner | Sep 20, 2015

Ferring Pharmaceuticals to host Phase 2b/3 trials of Selepressin
Wendell Hutson | Sep 20, 2015

Brintellix gets drug approval by FDA
Jamie Barrand | Sep 20, 2015

CPXample, HEADstrong Foundation partner on Blood Cancer Awareness Month initiatives

Trending
+ Pharmaceuticals
Patient Daily | Sep 12, 2025

Taxpayers Protection Alliance says 340B program is driving up taxpayer costs
+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+ Regulatory
Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
Patient Daily | Sep 15, 2025

Physician assistant on sinus issues and sleep disruption: ‘Any kind of sinus issue will always affect your sleep’